KUALA LUMPUR, May 20 -- LiveRamp®, the leading data connectivity platform announced its Authenticated Traffic Solution (ATS) has been adopted by hundreds of publishers, brands and platforms globally.
These include the US, UK, France, Italy, Spain, Germany, Australia and Japan, according to a statement. More than 70 demand and supply platforms and over 400 publishers, including 70 per cent of the Comscore 20 and 65 per cent of the Comscore 50, have adopted ATS to offer marketers a more efficient way to reach their customers and measure campaign outcomes without third-party cookies or device identifiers. “Simply put, ATS places publishers and marketers in control of their data. It generates better results for marketers, higher yields for publishers and provides the opportunity for greater transparency,” said LiveRamp Chief Executive Officer, Scott Howe. Publishers are leveraging ATS to enable people-based inventory and improve monetisation, including Microsoft Advertising, the world's second-largest publisher, which has seen a larger than 40 per cent increase in CPMs on authenticated impressions. The breadth of ATS adoption across the globe reveals that a variety of publishers see LiveRamp’s solution as not only viable to their business, but vital in serving their unique, diverse audiences. In addition, enabling hundreds of brand advertising campaigns in the first quarter of 2021 alone, ATS powers a people-based approach to connecting with audiences across all channels, making consumer interactions relevant, addressable and measurable. Garnering widespread platform support since its entry into the marketplace, the identifier is live with all major global supply-side platforms. ATS is also live on all major demand-side platforms, including Amobee, Beeswax, Criteo, MediaMath, Roku and The Trade Desk. More details at www.LiveRamp.com. -- BERNAMA
0 Comments
NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, EUROPEAN ECONOMIC AREA, THE UNITED KINGDOM, CANADA, JAPAN, AND AUSTRALIA
Record Demand from Global Investors Reflects Exceptional Support for the Growth Opportunities of the APAC and Quorn Businesses in the Philippines’ largest ever IPO SEC Approves Company’s Registration Statement and Issues Order of Registration and Permit to Sell Securities Sets June 1 as Planned Listing Day on the PSE MAKATI CITY, Phillippines, May 19 (Bernama-BUSINESS WIRE) -- Monde Nissin Corporation (“Monde Nissin” or the “Company”) has priced its proposed initial public offering (“IPO”) at Php13.50 per share. The IPO consists of 3,600,000,000 Common Shares (the “Offer”), with an overallotment option of a further 540,000,000 Common Shares granted by the Selling Shareholder. The Company also announced that the Philippine Securities and Exchange Commission (“SEC”) issued the Order of Registration and Permit to Sell, approving the Company’s proposed IPO on the Philippine Stock Exchange (“PSE”). The IPO is a landmark for the Philippines and Southeast Asia. The size of the Offer is the largest ever IPO on the PSE, and is also the largest ever Food & Beverage IPO in Southeast Asia. As part of the Offer, Monde Nissin secured 11 renowned cornerstone investors, who will form the long-term base of the Company’s share register. The cornerstone investors are: AIA Investment Management Private Limited, Stichting Depositary APG Emerging Markets Equity Pool, Avanda Investment Management Pte. Ltd., The Capital Group Funds, Eastspring Investments (Singapore) Limited, FIL Investment Management (Hong Kong) Limited, GIC Private Limited, Goldman Sachs Asset Management (Singapore) Pte. Ltd., M&G Investment Management Limited, NS Partners Ltd and RWC Asset Advisors (US) LLC. “We are pleased that these world-class investors share our vision of the future and will cornerstone our IPO,” said Henry Soesanto, Chief Executive Officer of Monde Nissin Corporation. “Their commitment is a strong vote of confidence in our company, strategy and talented team. We are excited about the opportunities that lie ahead as we accelerate our growth plans for our meat alternative business Quorn, which is a global player in the transformation of sustainably produced healthier food, and extend our leadership position in the Asia-Pacific Food and Beverage business through continued innovation and constant dialogue with our consumers.” The offer period for Philippines-based trading participants and retail investors will be from May 19, 2021 to May 25, 2021. Monde Nissin’s Common Shares are expected to begin trading on the Main Board of the PSE on June 1, 2021 under the stock symbol “MONDE”. As previously announced, the Company intends to use the net proceeds from the primary offer to fund capital expenditures, redeem the Arran Convertible Note and repay loans to commercial banks. A copy of Monde Nissin’s final prospectus is available on the Company’s website at https://mondenissin.com/company-prospectus/. UBS AG Singapore Branch, Citigroup Global Markets Limited and J.P. Morgan Securities plc are the Joint Global Coordinators and Joint Bookrunners for the proposed offering. BDO Capital & Investment Corporation, BPI Capital Corporation and First Metro Investment Corporation are the Local Lead Underwriters and Joint Bookrunners. Credit Suisse (Singapore) Limited is the Joint International Bookrunner. Macquarie Capital Securities (Singapore) Pte. Limited and Jefferies Singapore Limited are the International Co-Bookrunners. China Bank Capital Corporation, PNB Capital and Investment Corporation and SB Capital Investment Corp. are the Domestic Co-Lead Underwriters. This communication is not for distribution, directly or indirectly, in or into the United States (including is territories and possessions, any State of the United States and the District of Columbia). This communication is not an offer and does not form a part of any offer of securities for sale in the United States or elsewhere. The securities referenced herein have not been and will not be registered under the United States Securities Act of 1933 (the Securities Act), or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No money, securities or other consideration is being solicited by this communication or the information contained herein and, if sent in response to this communication or the information contained herein, will not be accepted. About Monde Nissin Monde Nissin Corporation is a global food and beverages company headquartered in the Philippines, with a portfolio of iconic and market leading brands across fast-growing categories, including Lucky Me! noodles, SkyFlakes crackers, Fita crackers, Monde baked goods and Quorn meat alternative products. The Company aspires to improve the well-being of people and the planet, and create sustainable solutions for food security. That aspiration is reflected in our commitment to continuously improve our products to make them more delicious, nutritious, and better for the planet. For more information, please visit www.mondenissin.com. About Quorn Quorn Foods is a global market leader in healthy, sustainable protein. Headquartered in Stokesley, North Yorkshire in the United Kingdom, the company offers a wide range of great-tasting products to appeal to the rapidly expanding group of people wanting to reduce their meat consumption. The company employs around 900 people and exports to 15 countries around the world, including Australia, Singapore and the United States. Quorn® is one of the United Kingdom’s top 40 FMCG brands. Quorn Foods Ltd is the reporting group which includes a main trading company, Marlow Foods Ltd. Quorn Foods Ltd encompasses all international operations of Quorn® and Cauldron®. For more information, please visit www.quorn.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006232/en/ Contact Media: Philippines Media Monde Nissin Mark Tiangco [email protected] International Media Sard Verbinnen & Co Ron Low, Jay Qin and Eve Young [email protected] Source : Monde Nissin Corporation --BERNAMA KUALA LUMPUR, May 19 (Bernama) -- XPOP will launch a new NFT marketplace in Southeast Asia, a market with strong K-POP fandom, this June-end. Comprising Korean gurus in blockchain technology and the entertainment business sectors, XPOP is an NFT blockchain technology company, specialising in utilising content service that has newly come into the limelight. The new NFT marketplace XPOP Project Team building will bring an innovative outcome to the entertainment market and its digital content industry. Based on a statement, various content players can make transactions on the smart contract of XPOP blockchain whenever they trade their own content engaged with them. As of present XPOP has reached an agreement with over 200 teams of K-POP artistes for rare content registration on XPOP NFT Marketplace. XPOP NFT Marketplace focuses on supporting music sources to assist in the growth of K-POP artistes. It also supports convenient and fast distribution of webcomics, games, art works, licences, and IP ownerships, which are relatively easier to be developed into digital products, in the global market through blockchain networks. This is an innovative entertainment platform where content creators, content industry players, and consumers communicate and trade with one another. Currently listed in Melon Exchange (melonex.io), XPOP Foundation is meeting various investors in domestic and international financial groups now. At the same time, XPOP is also engaging with general token holders while XPOP is getting listed on crypto exchange services continuously. -- BERNAMA NEW YORK, May 17 (Bernama-BUSINESS WIRE) -- A group of 16 international business and policy leaders today published an open letter to U.S. President Joseph R. Biden calling on him to “demonstrate decisive U.S. leadership now” to combat increasingly deadly Covid-19 outbreaks in Latin America, Europe and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511006247/en/ “The U.S. must act now to leverage rapidly increasing U.S. domestic vaccine production, export ever-larger volumes of our surplus supplies, and go to work on the massive technical and logistical challenges to vaccine development on a global scale,” the letter says, noting the rampant spread of the virus in places like India and the Philippines and the likelihood for mutations that will perpetuate globally if left unchecked. The letter also expresses opposition to the intellectual property waiver being promoted by the World Trade Organization, saying the move “would make little difference and could do harm” by not considering the steps necessary for safely manufacturing the vaccines. The full text of the letter is attached. Initiated by Maurice R. Greenberg, Chairman and CEO of C. V. Starr & Co., Inc., the letter is also signed by: Ken Langone, Chairman of the Board of Trustees of NYU Langone Health; Secretary William Cohen; Noel V. Lateef, Foreign Policy Association; Ambassador Carla A. Hills; Ambassador John D. Negroponte; Ambassador John F. Maisto; Alexander Feldman, U.S. ASEAN Business Council; Suzanne Clarke, U.S. Chamber of Commerce; Dr. Michelle McMurray-Heath, Biotechnology Innovation Organization (BIO); Adam S. Posen, Peterson Institute for International Economics; Hank Hendrickson, U.S. Philippines Society; Dr. John J. Hamre, Center for Strategic & International Studies; Dimitri Simes, Center for the National Interest; Ambassador Mark Green; and Dr. Robert Goldberg, Center for Medicine in the Public Interest. View source version on businesswire.com: https://www.businesswire.com/news/home/20210511006247/en/ Contact Joe Dillon Senior Vice President, External Affairs [email protected], 212-230-5073 Source : Starr & Co., Inc. --BERNAMA KUALA LUMPUR, May 17 (Bernama) -- PRA Health Sciences Inc has announced an innovative tokenisation solution using Synoma®, PRA’s proprietary technology, allowing for the generation of enhanced evidence for drug development.
PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. To date, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, use Synoma to link data and conduct analyses across their drug development portfolios, according to a statement. “Data of all types is widely available from dozens of sources. The missing link, however, is the ability to connect clinical trial data to the insights from real-world data – enabling researchers to understand what is happening outside and after a study in a way that protects privacy,” said PRA Health Sciences Executive Vice President and Chief Scientific Officer, Kent Thoelke. “Tokenisation and linking is the approach researchers can use to glean the greatest insights into drug safety and effectiveness over time.” Meanwhile, PRA Health Sciences Senior Vice President, Digital Health, Jane Quigley said: “Through our acquisition of Symphony Health and partnership with other data sources, we have enabled scientists and research teams to more intelligently evaluate a wider set of data to inform clinical trial protocols, leverage real-world data as eSource, conduct advanced feasibility, speed enrollment and, ultimately, bring novel and differentiated therapies to market faster.” PRA can partner with a variety of tokens to multiple sources of information – making it possible to incorporate broader sets of real-world data and revolutionise evidence generation and insights as envisioned by the 21st Century Cures Act. More details at www.prahs.com. -- BERNAMA |
Archives
April 2023
|